-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on BioNTech, Maintains $136 Price Target

Benzinga·09/08/2025 11:50:50
Listen to the news
HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $136 price target.